NIRA Skin
OperatingDermal Photonics Corp
Healthcare · Peabody, MA · Founded 2012
Dermatology at Home
Financials
FY2017–FY2018 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Fundraising history
Team
5 people
BSME, MBA Helped build Corning’s EDFA Laser business to 50% share Founded SemiNex Corp. & invented superior laser diodes for skin applications. Invented ultra-low-cost handheld laser underlying Dermal Photonics offering David currently serves as CEO of both SemiNex Corp and Dermal Photonics Corporation (dba NIRA Skin). He splits time between these roles, serving approximately 25 hours per week in his role as CEO of NIRA Skin.
BS, MS 25 years in lasers and optics MIT Lincoln Labs, Draper Labs, Corning Lasertron
M.D. 25 years experience in family practice Various hospital committees including: Quality Assurance, Preventative Health Task Force, Medical Management Council and Finance Committee 7 years as board member for New England Community Medical Group.
BA, MBA COO of Nutri System – grew to > $1B 25 years of retail management experience Entrepreneur Magazine called one of the 10 fastest growing franchise systems
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.